| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9905744 | European Journal of Cancer | 2005 | 5 Pages |
Abstract
In conclusion, response criteria as defined by RECIST are adequate to measure response and progression in non-GIST soft tissue sarcoma and can be used instead of the modified WHO criteria.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
P. Therasse, A. Le Cesne, M. Van Glabbeke, J. Verweij, I. Judson, for the EORTC Soft Tissue and Bone Sarcoma Group for the EORTC Soft Tissue and Bone Sarcoma Group,